tegafur has been researched along with Cancer of Intestines in 15 studies
Excerpt | Relevance | Reference |
---|---|---|
"In a prospective, multi-centre, randomized study of 109 patients with metastatic gastro-intestinal adenocarcinomas the response rate, survival time and side-effects of two drug combinations, carmustin +5-fluorouracil and carmustin + ftorafur, were compared (same carmustin dosage in both groups)." | 5.04 | [A prospective multi-centre study of the response of metastatic gastrointestinal tumours (author's transl)]. ( Arnold, H; Drings, P; Geldmacher, J; Hartwich, G; Kredel, L; Mayer, M; Neidhardt, B; Queisser, W; Rösch, W; Schaefer, J; von Oldershausen, HF; Wahrendorf, J, 1979) |
"Paclitaxel was given intravenously on days 1, 8, and 15, starting with a dose of 40 mg m-2 day-1." | 2.72 | Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer. ( Aihara, R; Asao, T; Haga, N; Kamiyama, Y; Kuwano, H; Mochiki, E; Nakabayashi, T; Nakamura, J; Ohno, T; Ohsawa, H; Ojima, H; Takeuchi, K, 2006) |
"Fluorouracil has been used for a long time, remission rates reported range from 0% to 80%." | 2.36 | [Chemotherapy of gastrointestinal tumors (review of the literature)]. ( Mayr, AC, 1978) |
"As there is no standard treatment for advanced gastric cancer refractory to first-line chemotherapy, the feasibility of S-1 plus weekly docetaxel combined with concurrent radiotherapy was evaluated." | 1.35 | Feasibility study of S-1 plus weekly docetaxel combined with concurrent radiotherapy in advanced gastric cancer refractory to first-line chemotherapy. ( Fujitani, K; Hirao, M; Kurokawa, Y; Tsujinaka, T; Yamasaki, H; Yoshida, K, 2009) |
"Forty patients with gastric cancer and 30 patients with colon cancer were administered FT-207 prior to the operation." | 1.26 | [Tissue concentration of 5-FU following pre-operative administration of FT-207]. ( Fukao, K; Ishikawa, A; Iwasaki, Y; Nagoshi, K; Okamura, T; Orii, K; Ozaki, A; Sarashina, H; Takase, Y; Takeshima, T; Todoroki, T, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (46.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 3 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takayoshi, K | 1 |
Kusaba, H | 1 |
Uenomachi, M | 1 |
Mitsugi, K | 1 |
Makiyama, C | 1 |
Makiyama, A | 1 |
Uchino, K | 1 |
Shirakawa, T | 1 |
Shibata, Y | 1 |
Shinohara, Y | 1 |
Inadomi, K | 1 |
Tsuchihashi, K | 1 |
Arita, S | 1 |
Ariyama, H | 1 |
Esaki, T | 1 |
Akashi, K | 1 |
Baba, E | 1 |
Fujitani, K | 1 |
Tsujinaka, T | 1 |
Yamasaki, H | 1 |
Hirao, M | 1 |
Yoshida, K | 1 |
Kurokawa, Y | 1 |
Aoki, Y | 1 |
Kameda, A | 1 |
Miyahara, E | 1 |
Funakoshi, M | 1 |
Okubo, K | 1 |
Yoshioka, S | 1 |
Asukai, K | 1 |
Hata, T | 1 |
Nakanishi, M | 1 |
Maekawa, T | 1 |
Hama, N | 1 |
Kashiwazaki, M | 1 |
Taniguchi, M | 1 |
Tsujie, M | 1 |
Konishi, M | 1 |
Yano, K | 1 |
Fujimoto, T | 1 |
Kotake, M | 1 |
Murakami, N | 1 |
Bandou, H | 1 |
Morita, K | 1 |
Koizumi, H | 1 |
Yoshino, H | 1 |
Tawaraya, K | 1 |
Ishiguro, K | 1 |
Kinoshita, S | 1 |
Yamada, T | 1 |
Ishizone, S | 1 |
Maruta, F | 1 |
Saito, H | 1 |
Koide, N | 1 |
Sugiyama, A | 1 |
Nakayama, J | 1 |
Miyagawa, S | 1 |
Mochiki, E | 1 |
Ohno, T | 1 |
Kamiyama, Y | 1 |
Aihara, R | 1 |
Haga, N | 1 |
Ojima, H | 1 |
Nakamura, J | 1 |
Ohsawa, H | 1 |
Nakabayashi, T | 1 |
Takeuchi, K | 1 |
Asao, T | 1 |
Kuwano, H | 1 |
Takayama, T | 1 |
Sato, Y | 1 |
Sagawa, T | 1 |
Okamoto, T | 1 |
Nagashima, H | 1 |
Takahashi, Y | 1 |
Ohnuma, H | 1 |
Kuroiwa, G | 1 |
Miyanishi, K | 1 |
Takimoto, R | 1 |
Matsunaga, T | 1 |
Kato, J | 1 |
Yamaguchi, K | 1 |
Hirata, K | 1 |
Niitsu, Y | 1 |
Davis, HL | 1 |
Sarashina, H | 1 |
Ozaki, A | 1 |
Okamura, T | 1 |
Fukao, K | 1 |
Takase, Y | 1 |
Takeshima, T | 1 |
Todoroki, T | 1 |
Ishikawa, A | 1 |
Orii, K | 1 |
Nagoshi, K | 1 |
Iwasaki, Y | 1 |
Okuda, M | 1 |
Teramoto, T | 1 |
Yoshida, H | 1 |
Sato, K | 1 |
Ushijima, Y | 1 |
Uematsu, Y | 1 |
Mayr, AC | 1 |
Sokova, OI | 1 |
Volgareva, GM | 1 |
Sawai, K | 1 |
Sonoda, Y | 1 |
Ohkuma, S | 1 |
Misawa, S | 1 |
Takino, T | 1 |
Queisser, W | 1 |
Schaefer, J | 1 |
Arnold, H | 1 |
Drings, P | 1 |
Geldmacher, J | 1 |
Hartwich, G | 1 |
Kredel, L | 1 |
Mayer, M | 1 |
Neidhardt, B | 1 |
von Oldershausen, HF | 1 |
Rösch, W | 1 |
Wahrendorf, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer[NCT01291407] | Phase 1 | 27 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for tegafur and Cancer of Intestines
Article | Year |
---|---|
[Chemotherapy of gastrointestinal tumors (review of the literature)].
Topics: Ancitabine; Carcinoma, Hepatocellular; Colonic Neoplasms; Doxorubicin; Drug Therapy, Combination; Fl | 1978 |
4 trials available for tegafur and Cancer of Intestines
Article | Year |
---|---|
Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Combinations; | 2006 |
Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Femal | 2007 |
Chemotherapy of large bowel cancer.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Floxuridine; Fluorouraci | 1982 |
[A prospective multi-centre study of the response of metastatic gastrointestinal tumours (author's transl)].
Topics: Adenocarcinoma; Carmustine; Fluorouracil; Gastrointestinal Neoplasms; Humans; Intestinal Neoplasms; | 1979 |
10 other studies available for tegafur and Cancer of Intestines
Article | Year |
---|---|
Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Beva | 2017 |
Feasibility study of S-1 plus weekly docetaxel combined with concurrent radiotherapy in advanced gastric cancer refractory to first-line chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doc | 2009 |
[A patient with small intestinal cancer and extensive lymph node metastasis who responded to S-1].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Drug Combinations; Endosc | 2010 |
[A case report of primary adenocarcinoma of small intestine].
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2010 |
[A case of primary small intestinal cancer accompanied by virchow lymph node metastasis undergoing TS-1 treatment].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2005 |
Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Dihydrouracil Dehydrogenase (NADP); | 2006 |
[Tissue concentration of 5-FU following pre-operative administration of FT-207].
Topics: Female; Fluorouracil; Humans; Intestinal Neoplasms; Intestine, Large; Lymph Nodes; Male; Middle Aged | 1982 |
[Clinical study of serum and tissue concentrations of FT-207 and 5-FU in patients with cancer of the large intestine following preoperative application of FT-207 suppositories].
Topics: Adult; Aged; Biological Assay; Female; Fluorouracil; Humans; Intestinal Neoplasms; Intestine, Large; | 1982 |
[Action of ftorafur and 5-fluorouracil on the chromosomes of normal and tumorous cells in vivo].
Topics: Animals; Bone Marrow; Bone Marrow Cells; Chromosomes; Cricetinae; Dose-Response Relationship, Drug; | 1977 |
[A combined immuno-chemotherapy with futraful and picibanil for advanced cancer (author's transl)].
Topics: Aged; Biological Products; Drug Therapy, Combination; Female; Fluorouracil; Humans; Intestinal Neopl | 1977 |